Back to companies

Clinuvel Pharmaceuticals Ltd: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of light related severe skin disorders. The company’s lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria (EPP) and is approved in Europe, Australia and the US for treating adult EPP patients. Its other products under development includes CUV9900 and VLRX001 among others. Clinuvel Pharmaceuticals also focused on developing a pediatric formulation of Scenesse for EPP and OTC products for general photoprotective application. The company through its subsidiaries has operations in Australia, Switzerland, Ireland, the UK, the US and Singapore. Clinuvel Pharmaceuticals is headquartered in Melbourne, Victoria, Australia.

Headquarters Australia

Address L 11 535 Bourke St, Melbourne, Victoria, 3000


Telephone 61 3 96604900

No of Employees 16

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CUV (ASX)

Revenue (2021) $33.3M 45.9% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 64.3% (2021 vs 2020)

Market Cap* $535.6M

Net Profit Margin (2021) XXX 12.7% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

30+

Clinical Trials

Determine Clinuvel Pharmaceuticals Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Catalyst Calendar

Proactively evaluate Clinuvel Pharmaceuticals Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

15+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Clinuvel Pharmaceuticals Ltd’s relevant decision makers and contact details.

6

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

6

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

4

Pipeline Drugs

Identify which of Clinuvel Pharmaceuticals Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Marketed Drugs

Understand Clinuvel Pharmaceuticals Ltd’s commercialized product portfolio to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Commercial: Scenesse
Scenesse (Afamelanotide) Prenumbra
Pipeline products:
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In February, the company announced the first disease-free subjects have received afamelanotide as part of the CUV151 mechanistic study to evaluate the impact of the drug on DNA damaged skin.
2021 Contracts/Agreements In November, the company entered into a longer term commercial agreement with one of its strategic partners for the scaled supply of adrenocorticotropic hormone (ACTH) drug substance to current Good Manufacturing Practices (cGMP) standard.
2021 Corporate Changes/Expansions In November, the company expanded its pharmaceutical development portfolio with NEURACTHEL, novel formulations of the melanocortin adrenocorticotropic hormone.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Clinuvel Pharmaceuticals Ltd MEI Pharma Inc Rhinomed Ltd Opthea Ltd biosensis Pty Ltd
Headquarters Australia United States of America Australia Australia Australia
City Melbourne San Diego Richmond Melbourne Thebarton
State/Province Victoria California Victoria Victoria South Australia
No. of Employees 16 76 - 5 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Phillipe J. Wolgen, Ph.D. Managing Director; Director; Chief Executive Officer Executive Board 2005 -
Darren M. Keamy Secretary; Chief Financial Officer Senior Management 2006 -
Dennis Wright, Ph.D. Chief Scientific Officer Senior Management - -
Willem Blijdorp Chairman Non Executive Board 2019 -
Lachlan Hay Director - Global Operations Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer